• Explore /
  • Poster
  • / Phase 2 study of livmoniplimab in combination with budigalimab in patients with hepatocellular carcinoma.

Phase 2 study of livmoniplimab in combination with budigalimab in patients with hepatocellular carcinoma.

Abstract Video & Slides Poster

Authors

Ghassan Abou-Alfa

Ghassan K. Abou-Alfa

Memorial Sloan Kettering Cancer Center, Weill Medical College at Cornell University, Trinity College Dublin, New York, NY

Ghassan K. Abou-Alfa , Chang-Fang Chiu , Fabio Piscaglia , Bruno Sangro , Anne Henkel , Hua Fang , Maulik Patel , Zhihong Ping , Claire Sutherland , Emarjola Bako , Cristiano Ferlini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

2022-502948-13-00

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS4189)

DOI

10.1200/JCO.2024.42.16_suppl.TPS4189

Abstract #

TPS4189

Poster Bd #

164b

Abstract Disclosures

Similar Posters

First Author: Arndt Vogel

First Author: Anne-Gaëlle Goubet

First Author: Matthew H. Taylor

First Author: Hailey Kathryn Carroll